Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 3, 2008, Pages 389-395

  Yonemori, Kan ^a   Yamaguchi, Umio ^a   Kaneko, Masayuki ^b   Uno, Hajime ^b   Takeuchi, Masahiro ^b   Ando, Masashi ^a   Fujiwara, Yasuhiro ^a   Hosono, Ako ^a   Makimoto, Atsushi ^a   Hasegawa, Tadashi ^c   Yokoyama, Ryouhei ^d   Nakatani, Fumihiko ^a   Kawai, Akira ^a   Beppu, Yasuo ^a   Chuman, Hirokazu ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Asian population; Chemotherapy; Ewing family of tumors; Predictive factor; Prognostic factor; Response

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; EWING SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIMARY HEALTH CARE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR LOCALIZATION;

ASIA; BONE NEOPLASMS; HUMANS; INCIDENCE; POPULATION GROUPS; PROGNOSIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SARCOMA, EWING'S; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 38649139895     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0295-9     Document Type: Article

References (28)

1. de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PH, Barr FG, Ladanyi M (1998) EWS-FL1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16:1248-1255
2. Bacci G, Ferrari S, Bertoni F, Rimondini S, Longhi A, Bacchini P, Forni C, Manfrini M, Donati D, Picci P (2000) Prognostic factors in nonmetastatic Ewing's sarcoma adjuvant chemotherapy: analysis of 359 patients at the Instituto Ostopedico Rizzoli. J Clin Oncol 18:4-11
3. Burdach S, Jurgens H, Peters C, Nurnberger W, Mauz-Korholz C, Korholz D, Paulussen M, Pape H, Diloo D, Kascielniak E, Gadner H, Gobel U (1993) Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 11:1482-1488
4. Burgert EO Jr, Nesbit ME, Garnsey LA, Gehan EA, Herrmann J, Vietti TJ, Cangir A, Tefft M, Evans E, Thomas P, Askin FB, Kissane JM, Prichard DJ, Neff J, Makley T, Giula L (1990) Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup study IESS-II. J Clin Oncol 8:1514-1524
5. Cardenas-Cardos R, Rivera-Luna R, Lopez-Facundo NA, Leal-leal C, Gomez-Martinez R, Catellanos-Toled A (1999) Ewing's sarcoma: prognosis and survival in Mexican children from a single institution. Pediatr Hematol Oncol 16:519-523
6. Catterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, Craft AW (2000) Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European intergroup cooperative Ewing's sarcoma study group. J Clin Oncol 18:3108-3114
7. El Weshi A, Memon M, Raja M, Bazarbashi S, Rahal M, El Foudeh M, Pai C, Allam A, El Hassan I, Ezzat A (2004) VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors. Am J Clin Oncol 27:529-534
8. Grier H, Krailo M, Tarbell N, Link MP, Fryer CJ, Prichard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing 's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694-701
9. Guo W, Xu W, Huvos AG, Healey JH, Feng C (1999) Comparative frequency of bone sarcomas among different racial group. Chin Med J 112:1101-1104
10. Jenkin DR, Al-Fawaz I, Al-Shabanah M, Allam A, Ayas M, Khafaga Y, Memon M, Rifai S, Shultz H, Younge D (2002) Localised Ewing sarcoma/PNET of bone prognostic factors and international data comparison. Med Pediatr Oncol 39:586-593
11. Jurgens H, Exner U, Gadner H, Harms D, Michaelis J, Sauer R, Treuner J, Voute T, Winkelmann W, Winkler K, Gobel U (1988) Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 61:23-32
12. Meyers PA, Wunder J, Healey J, Paulian G, Huvos A (1995) Ewing's sarcoma/primitive neurolectodermal tumor of bone: histological response to pre-operative chemotherapy predicts event free survival. Proc Meet Am Soc Clin Oncol 14:A1407
13. Meyers PA, Gorlick R, Heller G, Casper E, Lane J, Huvos AG, Healey JH (1998) Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Slone-Kettering (T12) protocol. J Clin Oncol 16:2452-2458
14. Miser JS, Kinsella TJ, Triche TJ, Steis R, Tsakos M, Wesley R, Harvath K, Belasco J, Longo DL, Glatstein E, Israel MA (1987) Treatment of neuroepiethelioma in children and young adults. J Clin Oncol 5:1752-1758
15. Nesbit ME Jr, Gehan EA, Burgert EO Jr, Vietti TJ, Cangir A, Tefft M, Evans R, Thomas P, Askin FB, Kissane JM, Prichard DJ, Herrmann J, Neff J, Makley JT, Gilula L (1990) Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: long-term follow-up of the First Intergroup study. J Clin Oncol 8:1664-1674
16. Obata H, Ueda T, Kawai A, Ishii T, Ozaki T, Abe S, Tanaka K, Tsuchiya H, Matsumine A, Yabe H (2007) Clinical outcome of patients with ewing sarcoma family of tumors of bone in Japan. Cancer 109:765-775
17. Ozaki T, Schaefer KL, Wai D, Yokoyama R, Ahrens S, Diallo R, Hasegawa T, Shimoda T, Hirohashi S, Kawai A, Naito N, Morimoto Y, Inoue H, Boecker W, Juergens H, Winkelmann W, Dockhorn-Dworniczak B, Premba C (2002) Population-based genetic alterations in Ewing's tumors from Japanese and European Caucasian patients. Ann Oncol 13:1656-1664
18. Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Katz R, Amann G, Dockhorn-Dwarniczak B, Harmas D, Muller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G., Gobel U, Treuner J, Voute PA, Zoubek A, Gadner H, Jurgens H (2001) Localized Ewing tumor of bones: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19:1818-1829
19. Rodriguez-Galindo C, Spunt SL, Pappo AS (2003) Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol 40:276-287
20. Shankar AG, Ashley S, Craft AW, Pinkerton CR (2003) Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Med Pediatr Oncol 40:141-147
21. Sluga M, Windhager R, Lang S, Heinzl H, Krepler P, Mittermayer F, Dominkus M, Zoubek A, Kots R (2001) A long-term review of the treatment of patients with Ewing's sarcoma in one institution. Eur J Surg Oncol 27:569-573
22. Stewart DA, Gyonyor E, Paterson AHG, Arthur K, Temple W, Schachar NS, Klassen J, Brown C, Russell JA (1996) High-dose melphalan ± total body irradiation and autologous hematopoietic stem cell rescue for adult patients with Ewing's sarcoma or peripheral neuroectodermal tumor. Bone Marrow Transplant 18:315-318
23. The JOA Musculo-Skeletal Tumor Committee (2003a) Bone tumor registry in Japan. National Cancer Center, Tokyo, pp 28-29
24. The JOA Musculo-Skeletal Tumor Committee (2003b) Malignant soft tissue tumor registry in Japan. National Cancer Center, Tokyo, pp 14-15
25. Villarroel M, Tordecilla J, Salgado C, Luo X, Messen S, Rayo Y, Zolezzi P, Rojas J (1997) Multimodal therapy for children and adolescents with Ewing sarcoma: results of the first national Chilean trial. Med Pediatr Oncol 29:190-196
26. World Health Organization (1979) WHO Handbook for reporting result of cancer treatment: offset publication 48, World Health Organization, Geneva
27. Yamada K, Sugiura H, Takahashi M (2006) Single center experience of treatment of Ewing's family of tumors in Japan. J Orthop Sci 11:34-42
28. Yamaguchi U, Hasegawa T, Morimoto Y, Tateishi U, Endo M, Nakatani F, Kawai A, Chuman H, Beppu Y, Endo M, Kurotaki H, Furuta K (2005) A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue. J Clin Pathol 58:1051-1056